Heterogeneity in the pathology and treatment of asthma

American Journal of Medicine

Volumn 115, Issue 3 SUPPL. 1, 2003, Pages 49-54

  Peters, Stephen P ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE; NONSTEROID ANTIINFLAMMATORY AGENT; SALBUTAMOL;

AIRWAY; ASTHMA; CONFERENCE PAPER; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; HUMAN; INFLAMMATION; PATHOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; T LYMPHOCYTE; TH2 CELL;

EID: 0043075805     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(03)00193-1     Document Type: Conference Paper

References (19)

1. Global initiative for asthma: global strategy for asthma management and prevention. Workshop report. NIH publication no. 95-3659, January 1995.
2. National Asthma Education and Prevention Program. Clinical Practice Guidelines: Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute; 1997. NIH publication 97-4051. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf. Accessed 5/30/03.
3. National Asthma Education and Prevention Program. Executive Summary of the NAEPP Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma - Update on Selected Topics 2002. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute; 2002. NIH publication no. 02-5075. Available at: http://www.nhlbi.nih.gov/guidelines/asthma. Accessed 5/30/03.
4. Busse W.W., Lemanske R.F. Jr. Advances in immunology asthma . N Engl J Med. 344:2001;350-362.
5. National Heart, Lung, and Blood Institute Data Fact Sheet: Asthma Statistics. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute; 1999. Available at: http://www.nhlbi.nih.gov/health/prof/lung/asthma/asthstat.pdf. Accessed 5/30/03.
6. O'Byrne P.M. Airway hyperresponsiveness. Middleton E. Jr, Reed C.E., Ellis E.F. Allergy, Principles and Practice. 5th ed:1988;859-866 Mosby, St. Louis, MO.
7. Cockcroft D.W., Killian D.N., Mellon J.J.A., Hargreave F.E. Bronchial reactivity to inhaled histamine a method and clinical survey . Clin Allergy. 7:1977;235-243.
8. Dunnill M.S. The pathology of asthma with special reference to changes in the bronchial mucosa. J Clin Pathol. 13:1960;27-33.
9. Carroll N., Elliot J., Morton A., James A. The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis. 147:1993;405-410.
10. Holgate S.T., Davies D.E., Lackie P.M., et al. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol. 105:2000;193-204.
11. Colavita A.M., Reinach A.J., Peters S.P. Contributing factors to the pathobiology of asthma the Th1/Th2 paradigm . Clin Chest Med. 21:2000;263-277.
12. Strachan D.P. Hay fever, hygiene, and household size. BMJ. 299:1989;1259-1260.
13. Ball T.M., Castro-Rodriguez J.A., Griffith K.A., et al. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med. 343:2000;538-543.
14. Wenzel S.E., Schwartz L.B., Langmack E.L., et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med. 160:1999;1001-1008.
15. Malmstrom K., Rodriguez-Gomez G., Guerra J., et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma a randomized, controlled trial . Ann Intern Med. 130:1999;487-495.
16. Szefler S.J., Martin R.J., King T.S., et al. National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol. 109:2002;410-418.
17. Guerra S., Sherrill D.L., Martinez F.D., Barbee R.A. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol. 109:2002;419-425.
18. Adams R.J., Fuhlbrigge A.L., Finkelstein J.A., Weiss S.T. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol. 109:2002;636-642.
19. Harding S.M. Gastroesophageal reflux and asthma insight into the association . J Allergy Clin Immunol. 104:1999;251-259.